No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations spanning pharmaceuticals, cosmetics, hair dye manufacturing, and photodynamic therapy. Its extensive product range includes a broad selection of over-the-counter (OTC) medications designed to treat a variety of conditions. These encompass liver ailments, menopausal symptoms, skin disorders, obesity, digestive and gum health issues, and hair loss. The company's OTC offerings also feature remedies for fever, pain, inflammation, respiratory illnesses, scar reduction, and sleep disturbances, along with antiviral, anti-diarrhea, anti-nausea, blood circulation enhancing, antifungal, and antihistamine drugs. Supplementary OTC products include keratin softeners, eye nutrition supplements, and essential vitamins. Furthermore, Dong Sung Bio Pharm produces ethical (prescription-only, or ETC) drugs. These target specific medical areas such as endocrine, gastrointestinal, circulatory, neuropsychological, and oncological conditions. Its ETC portfolio also contains analgesic and anti-inflammatory agents, dermato-urinary treatments, antiviral, antibiotic, antifungal, and antihistamine medications, as well as respiratory drugs, steroids, and ophthalmic drops. Beyond its pharmaceutical lines, the company offers a range of consumer health and personal care items. These include hair coloring products, functional health foods, medical devices, various daily necessities, muscle taping supplies, disinfectants, toothpastes, shampoos for anti-hair loss and hair growth, and sanitary pads. Dong Sung Bio Pharm.Co.,Ltd. was founded in 1957 and maintains its headquarters in Seoul, South Korea.
dongsung-pharm.comNo one on the platform currently holds 002210.KS.
No tracked institution reports a position in 002210.KS as of their last filing.
No one on the platform has traded 002210.KS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 002210.KSDong Sung Bio Pharm.Co.,Ltd. | $1359.00 | -0.51% | $33.2B | — |
| 000020.KSDongwha Pharm.Co.,Ltd | $5050.00 | -1.94% | $140.0B | — |
| 000640.KSDong-A Socio Holdings Co., Ltd. | $92400.00 | -2.12% | $622.1B | — |
| 001630.KSChong Kun Dang Holdings Corp. | $38200.00 | -0.91% | $181.9B | — |
| 003000.KSBukwang Pharmaceutical Co., Ltd. | $3860.00 | +0.39% | $380.8B | — |
| 003060.KSAprogen Biologics Inc. | $1608.00 | -1.95% | $21.2B | — |
| 086450.KQDongKook Pharmaceutical Co., Ltd. | $20650.00 | +1.72% | $931.5B | — |
Source: Financial Modeling Prep · peers by sector/industry